| Antibiotics tested | Antimicrobials resistance to ESBL positive (n = 61) | Antimicrobials resistance to ESBL negatives (n = 23) |
| Ampicillin | 89.5% | 58.2% |
| Amoxiclave | 89.3% | 51.5% |
| Amikacin | 5.6% | 1.9% |
| Azithromicine | 48.1% | 21.0% |
| Aztreonam | 100.0% | 100.% |
| Ceftazidime | 81.2% | 50.8% |
| Ceftriaxone | 80.8% | 31.8% |
| Cefotaxime | 77.3% | 38.1% |
| Gentamicine | 44.7% | 38.0% |
| Ciprofloxacin | 84.4% | 74.4% |
| Nitrofurantoin | 0.0% | 0.0% |
| Piperacillin | 100.0% | 100.0% |
| Imipenem | 0.0% | 0.0% |
| Co-trimoxazole | 85.1% | 46.3% |